These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 8721982

  • 1. Formation and activation by phosphorylation of activin receptor complexes.
    Willis SA, Zimmerman CM, Li LI, Mathews LS.
    Mol Endocrinol; 1996 Apr; 10(4):367-79. PubMed ID: 8721982
    [Abstract] [Full Text] [Related]

  • 2. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
    Cárcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J.
    Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
    [Abstract] [Full Text] [Related]

  • 3. Regulation of activin type I receptor function by phosphorylation of residues outside the GS domain.
    Willis SA, Mathews LS.
    FEBS Lett; 1997 Dec 29; 420(2-3):117-20. PubMed ID: 9459292
    [Abstract] [Full Text] [Related]

  • 4. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.
    Xu J, McKeehan K, Matsuzaki K, McKeehan WL.
    J Biol Chem; 1995 Mar 17; 270(11):6308-13. PubMed ID: 7890768
    [Abstract] [Full Text] [Related]

  • 5. Identification of a functional binding site for activin on the type I receptor ALK4.
    Harrison CA, Gray PC, Koerber SC, Fischer W, Vale W.
    J Biol Chem; 2003 Jun 06; 278(23):21129-35. PubMed ID: 12665502
    [Abstract] [Full Text] [Related]

  • 6. Identification of a binding site on the type II activin receptor for activin and inhibin.
    Gray PC, Greenwald J, Blount AL, Kunitake KS, Donaldson CJ, Choe S, Vale W.
    J Biol Chem; 2000 Feb 04; 275(5):3206-12. PubMed ID: 10652306
    [Abstract] [Full Text] [Related]

  • 7. Two distinct signaling pathways activated by activin A in glucose-responsive pancreatic beta-cell lines.
    Shibata H, Kanzaki M, Takeuchi T, Miyazaki J, Kojima I.
    J Mol Endocrinol; 1996 Jun 04; 16(3):249-58. PubMed ID: 8782083
    [Abstract] [Full Text] [Related]

  • 8. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
    Donaldson CJ, Vaughan JM, Corrigan AZ, Fischer WH, Vale WW.
    Endocrinology; 1999 Apr 04; 140(4):1760-6. PubMed ID: 10098513
    [Abstract] [Full Text] [Related]

  • 9. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
    Macías-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL.
    J Biol Chem; 1998 Oct 02; 273(40):25628-36. PubMed ID: 9748228
    [Abstract] [Full Text] [Related]

  • 10. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
    Alexander JM, Bikkal HA, Zervas NT, Laws ER, Klibanski A.
    J Clin Endocrinol Metab; 1996 Feb 02; 81(2):783-90. PubMed ID: 8636304
    [Abstract] [Full Text] [Related]

  • 11. Inactivation of activin-dependent transcription by kinase-deficient activin receptors.
    Tsuchida K, Vaughan JM, Wiater E, Gaddy-Kurten D, Vale WW.
    Endocrinology; 1995 Dec 02; 136(12):5493-503. PubMed ID: 7588300
    [Abstract] [Full Text] [Related]

  • 12. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
    Takumi T, Moustakas A, Lin HY, Lodish HF.
    Exp Cell Res; 1995 Jan 02; 216(1):208-14. PubMed ID: 7813622
    [Abstract] [Full Text] [Related]

  • 13. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
    Ebner R, Chen RH, Lawler S, Zioncheck T, Derynck R.
    Science; 1993 Nov 05; 262(5135):900-2. PubMed ID: 8235612
    [Abstract] [Full Text] [Related]

  • 14. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
    Lebrun JJ, Vale WW.
    Mol Cell Biol; 1997 Mar 05; 17(3):1682-91. PubMed ID: 9032295
    [Abstract] [Full Text] [Related]

  • 15. The role of activin type I receptors in activin A-induced growth arrest and apoptosis in mouse B-cell hybridoma cells.
    Hashimoto O, Yamato K, Koseki T, Ohguchi M, Ishisaki A, Shoji H, Nakamura T, Hayashi Y, Sugino H, Nishihara T.
    Cell Signal; 1998 Nov 05; 10(10):743-9. PubMed ID: 9884026
    [Abstract] [Full Text] [Related]

  • 16. Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors.
    De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ.
    Exp Cell Res; 1996 May 01; 224(2):323-34. PubMed ID: 8612709
    [Abstract] [Full Text] [Related]

  • 17. The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction.
    Franzén P, Heldin CH, Miyazono K.
    Biochem Biophys Res Commun; 1995 Feb 15; 207(2):682-9. PubMed ID: 7864860
    [Abstract] [Full Text] [Related]

  • 18. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor.
    Matsuzaki K, Xu J, Wang F, McKeehan WL, Krummen L, Kan M.
    J Biol Chem; 1993 Jun 15; 268(17):12719-23. PubMed ID: 8389764
    [Abstract] [Full Text] [Related]

  • 19. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta.
    Saitoh M, Nishitoh H, Amagasa T, Miyazono K, Takagi M, Ichijo H.
    J Biol Chem; 1996 Feb 02; 271(5):2769-75. PubMed ID: 8576253
    [Abstract] [Full Text] [Related]

  • 20. Activin and its receptors during gastrulation and the later phases of mesoderm development in the chick embryo.
    Stern CD, Yu RT, Kakizuka A, Kintner CR, Mathews LS, Vale WW, Evans RM, Umesono K.
    Dev Biol; 1995 Nov 02; 172(1):192-205. PubMed ID: 7589799
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.